The Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Curr Opin Gastroenterol. 2022 Jul 1;38(4):373-381. doi: 10.1097/MOG.0000000000000845.
Telemedicine has quickly become an essential part of modern healthcare, particularly in the management of chronic conditions like inflammatory bowel disease. The purpose of this review is to describe the current use of telehealth, mobile applications and wearable devices in inflammatory bowel disease and potential future applications.
Telemedicine was increasingly used during the Coronavirus Disease 2019 pandemic. Virtual consultations allowed clinical care to continue despite pandemic-related restrictions without compromising the quality of care for patients with inflammatory bowel disease (IBD). It also benefits patients who would not have access to care due to financial or geographical barriers. Mobile applications allow patients with IBD to record disease activity among other metrics, allowing for earlier healthcare provider intervention. Wearable devices are increasingly being explored to monitor physiological indicators of disease activity and flare.
Telehealth and remote patient monitoring has been successfully integrated into the care of IBD patients. The advantages of these modalities include better access to specialist care and remote noninvasive disease monitoring. Careful consideration must be given to patient privacy, data protection and equitable access. These modalities have enormous potential to improve patient care through accurate consistent data collection and even the prediction of disease activity.
远程医疗已迅速成为现代医疗保健的重要组成部分，在炎症性肠病等慢性病的管理中尤其如此。本文旨在描述远程医疗、移动应用程序和可穿戴设备在炎症性肠病中的当前应用以及潜在的未来应用。
在 2019 年冠状病毒病大流行期间，远程医疗的使用越来越多。虚拟咨询使临床护理能够继续进行，尽管受到与大流行相关的限制，但不会影响炎症性肠病（IBD）患者的护理质量。它还使那些因经济或地理障碍而无法获得护理的患者受益。移动应用程序允许 IBD 患者记录疾病活动等指标，以便医疗保健提供者更早地进行干预。可穿戴设备越来越多地被用于监测疾病活动和发作的生理指标。
远程医疗和远程患者监测已成功整合到 IBD 患者的护理中。这些模式的优点包括更好地获得专科护理和远程非侵入性疾病监测。必须仔细考虑患者隐私、数据保护和公平获取这些模式通过准确一致的数据收集，甚至疾病活动的预测，具有巨大的改善患者护理的潜力。
